je.st
news
Home
› Johnson & Johnson starts first disease-interception projects, targeting diabetes and lab tests
Johnson & Johnson starts first disease-interception projects, targeting diabetes and lab tests
2015-06-11 16:06:20| Biotech - Topix.net
This undated product image provided by Johnson & Johnson shows Emulate's Organ-On-Chips technology, a computer chip designed to simulate functions of human organs to predict which experimental drugs are most likely to be effective and safe in people. The project is aimed at limiting the failure of drugs after they get into expensive testing in patients.
Tags: projects
tests
johnson
starts
Category:Biotechnology and Pharmaceuticals